|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 0.1713 USD | +8.76% |
|
-1.66% | -90.54% |
| 09-01 | VivoSim Labs Plans To Develop Rat Liver Model To Complement NAMkind Human Liver Platform | CI |
| 08-12 | VivoSim Labs, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 2.84M 2.53M 2.34M 2.12M 3.99M 269M 4.06M 28.12M 11.05M 141M 10.66M 10.44M 449M | P/E 2025 |
-1.32x | P/E 2026 | -0.27x |
|---|---|---|---|---|---|
| Enterprise Value | -1.62M -1.44M -1.33M -1.21M -2.27M -153M -2.31M -16.01M -6.29M -80.2M -6.07M -5.94M -256M | EV / Sales 2025 |
-43,384,333x | EV / Sales 2026 | -5,569,580x |
| Free-Float |
97.33% | Yield 2025 * |
-
| Yield 2026 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VIVS | Delayed | |
London S.E.
| 0R02 | Delayed | |
|
CBOE
| VIVS | Real-time |
| 1 day | +8.76% | ||
| 1 week | -1.66% | ||
| Current month | -19.20% | ||
| 1 month | -24.54% | ||
| 3 months | -66.07% | ||
| 6 months | -88.88% | ||
| Current year | -90.54% |
| 1 week | 0.15 |  | 0.19 |
| 1 month | 0.15 | | 0.26 |
| Current year | 0.15 | | 3.4 |
| 1 year | 0.15 | | 3.4 |
| 3 years | 0.15 | | 24.6 |
| 5 years | 0.15 | | 79.08 |
| 10 years | 0.15 | | 979.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Keith Murphy
CEO | Chief Executive Officer | 55 | 2006-12-31 |
Norman Staskey
DFI | Director of Finance/CFO | 56 | 2024-12-29 |
Amar Sethi
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-05 |
| Director | Title | Age | Since |
|---|---|---|---|
Adam Stern
BRD | Director/Board Member | 61 | 2012-01-31 |
Keith Murphy
CHM | Chairman | 55 | 2006-12-31 |
David Gobel
BRD | Director/Board Member | 73 | 2020-09-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Buy | Executive/Senior Manager | 10,000 | 0.3846% | ||
| 1/27/26 | Free | Director | 15,000 | 0.5770% | ||
| 1/27/26 | Free | Director | 15,000 | 0.5770% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.76% | -1.66% | -93.09% | -98.79% | 2.61M | |
| +0.79% | -6.16% | +49.32% | +74.50% | 65.83B | |
| +1.92% | +10.35% | +13.02% | +87.74% | 51.87B | |
| +6.91% | +8.57% | +6.88% | +72.12% | 51.2B | |
| +0.74% | +2.75% | +26.31% | +45.29% | 43.76B | |
| +3.87% | +10.15% | +20.69% | +132.73% | 42.09B | |
| +7.91% | +4.30% | +263.91% | +602.72% | 39.04B | |
| -0.40% | +9.85% | +17.04% | +59.17% | 34B | |
| +0.20% | +0.72% | +39.09% | +8.56% | 25.2B | |
| +2.36% | +5.34% | +30.98% | +26.07% | 22.8B | |
| Average | +3.30% | +1.33% | +37.41% | +101.01% | 37.58B | |
| Weighted average by Cap. | +2.80% | +2.01% | +50.21% | +125.25% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 0.14 0.13 0.12 0.11 0.2 13.64 0.21 1.43 0.56 7.14 0.54 0.53 22.77 | 0.13 0.12 0.11 0.1 0.18 12.41 0.19 1.3 0.51 6.49 0.49 0.48 20.72 |
| Net income | -2.49M -2.21M -2.05M -1.86M -3.5M -236M -3.55M -24.63M -9.67M -123M -9.33M -9.14M -393M | -13.84M -12.32M -11.42M -10.35M -19.45M -1.31B -19.77M -137M -53.83M -686M -51.93M -50.85M -2.19B |
| Net Debt | -10.24M -9.12M -8.45M -7.66M -14.39M -970M -14.63M -101M -39.83M -508M -38.42M -37.62M -1.62B | -4.46M -3.97M -3.68M -3.33M -6.26M -422M -6.37M -44.14M -17.34M -221M -16.73M -16.38M -705M |
Employees
15
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | US$0.1713 | +8.76% | 662,938 |
| 26-10-19 | US$0.1575 | +0.38% | 359,442 |
| 26-10-16 | US$0.1569 | -8.25% | 827,691 |
| 26-10-15 | US$0.1710 | +6.28% | 3,517,414 |
| 26-10-14 | US$0.1609 | -7.63% | 362,794 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- VIVS Stock
Select your edition
All financial news and data tailored to specific country editions
